Advertisement
Screener

McKESSON CORPORATION (MCK) Research and Development Expense

2.8 / 5 stars · 68/120 Roast Me

McKESSON CORPORATION Research and Development Expense

McKESSON CORPORATION (MCK) reported Research and Development Expense of $96.00 million for the 12-month period ending 2020-03-31, per its 10-K filed 2020-05-22.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2020-05-22

  • McKESSON CORPORATION research and development expense for fiscal 2020 was $96.00M, a 35.21% increase from fiscal 2019.
  • McKESSON CORPORATION research and development expense for fiscal 2019 was $71.00M, a 43.20% decline from fiscal 2018.
  • McKESSON CORPORATION research and development expense for fiscal 2018 was $125.00M, a 63.34% decline from fiscal 2017.
  • McKESSON CORPORATION research and development expense for fiscal 2017 was $341.00M, a 13.01% decline from fiscal 2016.
Period endResearch and Development Expense 12 monthResearch and Development Expense 12 month as first filed
2020-03-31$96.00M
10-K · filed 2020-05-22
2019-03-31$71.00M
10-K · filed 2020-05-22
2018-03-31$125.00M
10-K · filed 2020-05-22
2017-03-31$341.00M
10-K · filed 2019-05-15
2016-03-31$392.00M
10-K · filed 2018-05-24
2015-03-31$392.00M
10-K · filed 2017-05-22
2014-03-31$457.00M
10-K · filed 2016-05-05
$456.00M
10-K · filed 2014-05-14
2013-03-31$433.00M
10-K · filed 2015-05-12
$480.00M
10-K · filed 2013-05-07
2012-03-31$402.00M
10-K · filed 2014-05-14
$440.00M
10-K · filed 2012-05-02
2011-03-31$407.00M
10-K · filed 2013-05-07
2010-03-31$376.00M
10-K · filed 2012-05-02
2009-03-31$364.00M
10-K · filed 2011-05-05
2008-03-31$347.00M
10-K · filed 2010-05-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cencora, Inc. (COR)United States$59.130B20.57
CARDINAL HEALTH INC (CAH)United States$51.753B29.38
HERBALIFE LTD. (HLF)$1.281B8.39
NU SKIN ENTERPRISES, INC. (NUS)United States$0.225B-1.18
Cosmos Health Inc. (COSM)Greece$0.038B-0.60
HWH International Inc. (HWH)United States$0.021B-4.08
DataMeds AI, Inc. (MEDS)United States$0.011B